'Generic to genetic' transition in cardiovascular and neuropsychiatric drugs: opportunity for personalized medicine

Pharmacogenomics. 2012 Jul;13(10):1097-100. doi: 10.2217/pgs.12.75.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural

MeSH terms

  • Cardiovascular Diseases* / drug therapy
  • Cardiovascular Diseases* / genetics
  • Drugs, Generic
  • Humans
  • Pharmacogenetics
  • Precision Medicine*
  • Prescription Drugs
  • Psychotic Disorders* / drug therapy
  • Psychotic Disorders* / genetics

Substances

  • Drugs, Generic
  • Prescription Drugs